Journal of clinical psychopharmacology
Journal
Identity
International Standard Serial Number (ISSN)
Other
publication venue for
-
Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol..
27:126-134.
2007
-
Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs..
26:519-523.
2006
-
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features..
24:365-373.
2004
-
Olanzapine versus placebo in acute mania: treatment responses in subgroups..
23:370-376.
2003
-
Acute dysphoric mania: treatment response to olanzapine versus placebo..
23:132-137.
2003
-
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine..
22:450-454.
2002
-
Interactive model of therapeutic response in panic disorder: moclobemide, a case in point..
22:275-284.
2002
-
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder..
21:469-473.
2001
-
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania..
21:389-397.
2001
-
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America..
21:375-381.
2001
-
Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication..
20:622-627.
2000
-
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders..
19:23S-29S.
1999
-
International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997..
18:27S-31S.
1998
-
Issues in the long-term treatment of panic disorder..
18:-.
1998
-
Moclobemide in social phobia: a controlled dose-response trial..
17:247-254.
1997
-
Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders..
14:311-313.
1994
-
Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders..
14:67-70.
1994
-
Preference for diazepam in anxious adults..
10:190-196.
1990
-
Risks and benefits of long-term benzodiazepine use..
8:161-167.
1988
-
Long-term response to carbamazepine: a retrospective study..
8:130-132.
1988
-
The value of self-report assessment in studies of anxiety disorders..
7:215-221.
1987
-
Plasma concentrations of imipramine and clinical response among depressed outpatients..
2:140-142.
1982
-
Dispelling myths about benzodiazepines.
1999